How modern treatments have modified the role of surgery in pediatric low-grade glioma
Authors:
Open Access
- 27 April 2024
- journal article
- review article
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (10) , 3357-3365
Abstract
Low-grade gliomas are the most common brain tumor of childhood, and complete resection offers a high likelihood of cure. However, in many instances, tumors may not be surgically accessible without substantial morbidity, particularly in regard to gliomas arising from the optic or hypothalamic regions, as well as the brainstem. When gross total resection is not feasible, alternative treatment strategies must be considered. While conventional chemotherapy and radiation therapy have long been the backbone of adjuvant therapy for low-grade glioma, emerging techniques and technologies are rapidly changing the landscape of care for patients with this disease. This article seeks to review the current and emerging modalities of treatment for pediatric low-grade glioma.Keywords
This publication has 60 references indexed in Scilit:
- Slipped capital femoral epiphyses: A major on‐target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patientsPediatric Blood & Cancer, 2023
- Trametinib therapy for children with neurofibromatosis type 1 and life‐threatening plexiform neurofibroma or treatment‐refractory low‐grade gliomaCancer Medicine, 2021
- A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade gliomaPediatric Blood & Cancer, 2020
- MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain2019
- Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson DiseaseJAMA Neurology, 2017
- Neurosurgical tools to extend tumor resection in pediatric hemispheric low-grade gliomas: iMRIChild's Nervous System, 2016
- Nonrandomized comparison of neurofibromatosis type 1 and non–neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low‐grade glioma: A report from the Children's Oncology GroupCancer, 2016
- Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomasChild's Nervous System, 2015
- Vemurafenib in pediatric patients with BRAFV600E mutated high‐grade gliomasPediatric Blood & Cancer, 2013
- BRAFV600E mutation is a negative prognosticator in pediatric gangliogliomaActa Neuropathologica, 2013